Author:
Auyeung Vivian,Patel Jignesh P.,Abdou John K.,Vadher Bipin,Bonner Lynda,Brown Alison,Roberts Lara N.,Patel Raj K.,Arya Roopen
Publisher
Springer Science and Business Media LLC
Subject
Hematology,Molecular Biology
Reference47 articles.
1. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Khan SR. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2_suppl):e419s–94s.
2. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GYH. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidenced-Based Clinical Practice Guidelines. Chest. 2012;141(2_suppl):e531s–75s.
3. Beyth RJ, Antani MR, Covinsky KE, Miller DG, Chren MM, Quinn LM, Landerfeld CS. Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med. 1996;11(12):721–8.
4. Dentali F, Riva N, Crowther M, Turpie AGG, Lip GYH, Ageno W. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation. 2012;126:2381–91.
5. Anon. National Institute for Health and Care Excellence. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. TA249. March 2012. Accessed online at http://guidance.nice.org.uk/ta249 .
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献